These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 34307189)
1. Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer. Gao R; Zhu Y; Kong C; Xia K; Li H; Zhu Y; Zhang X; Liu Y; Zhong H; Yang R; Chen C; Qin N; Qin H Front Cell Infect Microbiol; 2021; 11():657867. PubMed ID: 34307189 [TBL] [Abstract][Full Text] [Related]
2. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes. Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266 [TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer. Avuthu N; Guda C Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483 [TBL] [Abstract][Full Text] [Related]
4. Distinct gut microbiomes in Thai patients with colorectal polyps. Intarajak T; Udomchaiprasertkul W; Khoiri AN; Sutheeworapong S; Kusonmano K; Kittichotirat W; Thammarongtham C; Cheevadhanarak S World J Gastroenterol; 2024 Jul; 30(27):3336-3355. PubMed ID: 39086748 [TBL] [Abstract][Full Text] [Related]
5. Different Characteristics in Gut Microbiome between Advanced Adenoma Patients and Colorectal Cancer Patients by Metagenomic Analysis. Han S; Zhuang J; Pan Y; Wu W; Ding K Microbiol Spectr; 2022 Dec; 10(6):e0159322. PubMed ID: 36453905 [TBL] [Abstract][Full Text] [Related]
6. Expanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome. Shen S; Huo D; Ma C; Jiang S; Zhang J Microbiol Spectr; 2021 Dec; 9(3):e0009021. PubMed ID: 34935421 [TBL] [Abstract][Full Text] [Related]
7. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls. Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031 [TBL] [Abstract][Full Text] [Related]
8. Expansion of Colorectal Cancer Biomarkers Based on Gut Bacteria and Viruses. Zhang J; He Y; Xia L; Yi J; Wang Z; Zhao Y; Song X; Li J; Liu H; Liang X; Nie S; Liu L Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230584 [TBL] [Abstract][Full Text] [Related]
9. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940 [TBL] [Abstract][Full Text] [Related]
10. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis. Huh JW; Roh TY BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of fecal viromes demonstrates high diagnostic potential of the gut viral signatures for colorectal cancer and adenoma risk assessment. Chen F; Li S; Guo R; Song F; Zhang Y; Wang X; Huo X; Lv Q; Ullah H; Wang G; Ma Y; Yan Q; Ma X J Adv Res; 2023 Jul; 49():103-114. PubMed ID: 36198381 [TBL] [Abstract][Full Text] [Related]
12. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits. Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577 [TBL] [Abstract][Full Text] [Related]
13. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis. Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome. Hannigan GD; Duhaime MB; Ruffin MT; Koumpouras CC; Schloss PD mBio; 2018 Nov; 9(6):. PubMed ID: 30459201 [TBL] [Abstract][Full Text] [Related]
15. Alterations in colorectal cancer virome and its persistence after surgery. Ho SX; Law JH; Png CW; Alberts R; Zhang Y; Chu JJH; Tan KK Sci Rep; 2024 Feb; 14(1):2819. PubMed ID: 38307921 [TBL] [Abstract][Full Text] [Related]
16. Altered Mycobiota Signatures and Enriched Pathogenic Aspergillus rambellii Are Associated With Colorectal Cancer Based on Multicohort Fecal Metagenomic Analyses. Lin Y; Lau HC; Liu Y; Kang X; Wang Y; Ting NL; Kwong TN; Han J; Liu W; Liu C; She J; Wong SH; Sung JJ; Yu J Gastroenterology; 2022 Oct; 163(4):908-921. PubMed ID: 35724733 [TBL] [Abstract][Full Text] [Related]
17. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions. Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748 [TBL] [Abstract][Full Text] [Related]
18. Integration of constraint-based modeling with fecal metabolomics reveals large deleterious effects of Hertel J; Heinken A; Martinelli F; Thiele I Gut Microbes; 2021; 13(1):1-23. PubMed ID: 34057024 [TBL] [Abstract][Full Text] [Related]
19. Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer. Zhang H; Jin K; Xiong K; Jing W; Pang Z; Feng M; Cheng X Cancer Med; 2023 Jul; 12(14):15720-15735. PubMed ID: 37260140 [TBL] [Abstract][Full Text] [Related]
20. Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences. Tortora SC; Bodiwala VM; Quinn A; Martello LA; Vignesh S World J Gastrointest Oncol; 2022 Feb; 14(2):375-395. PubMed ID: 35317317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]